Plant ID: NPO16886
Plant Latin Name: Amorpha fruticosa
Taxonomy Genus: Amorpha
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
48131
Plant-of-the-World-Online:
n.a.
India; China
GAA; | |
MAPK1; | |
PPARA; PPARG; | |
ALDH1A1; | |
TP53; | |
MAPT; RAB9A; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.745E-09 | 5.978E-05 | CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 8.143E-07 | 2.533E-03 | CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.924E-06 | 5.238E-03 | CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 2.946E-06 | 6.285E-03 | PPARA, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 4.417E-06 | 6.412E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 4.417E-06 | 6.412E-03 | PPARA, PPARG |
MF | GO:0005488; binding | GO:0097371; MDM2/MDM4 family protein binding | 6.182E-06 | 7.918E-03 | PPARA, TP53 |
BP | GO:0007610; behavior | GO:0007610; behavior | 6.736E-06 | 8.149E-03 | GAA, MAPK1, MAPT, PPARA, TP53 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 3.991E-05 | 2.069E-02 | CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0020037; heme binding | 4.511E-05 | 2.183E-02 | CYP2C19, CYP2C9, CYP2D6 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 2.983E-07 | 2.580E-05 | CYP2C9, CYP2D6, MAPK1, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 4.487E-07 | 2.580E-05 | MAPK1, PPARG, TP53 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 6.357E-06 | 2.437E-04 | CYP2C9, CYP2D6, CYP2C19 |
09160 Human Diseases | 09167 Infectious diseases | hsa05160 | Hepatitis C | 4.562E-05 | 1.312E-03 | MAPK1, PPARA, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 3.133E-04 | 4.282E-03 | MAPK1, MAPT, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 2.229E-04 | 4.272E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05223 | Non-small cell lung cancer | 4.167E-04 | 4.282E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05213 | Endometrial cancer | 3.592E-04 | 4.282E-03 | MAPK1, TP53 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.108E-04 | 2.547E-03 | CYP2C9, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 5.613E-04 | 4.282E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 5.108E-04 | 4.282E-03 | MAPK1, TP53 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 5.108E-04 | 4.282E-03 | CYP2C9, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 5.787E-04 | 4.282E-03 | MAPK1, TP53 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 5.613E-04 | 4.282E-03 | CYP2C9, ALDH1A1 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 1.138E-03 | 5.847E-03 | MAPK1, PPARG, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 5.963E-04 | 4.282E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05218 | Melanoma | 6.694E-04 | 4.282E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 7.075E-04 | 4.282E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 1.049E-03 | 5.746E-03 | MAPK1, TP53 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.075E-04 | 4.282E-03 | CYP2C9, CYP2D6 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 6.323E-04 | 4.282E-03 | PPARG, PPARA |
09150 Organismal Systems | 09149 Aging | hsa04211 | Longevity regulating pathway - mammal | 1.169E-03 | 5.847E-03 | PPARG, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 8.917E-04 | 5.127E-03 | CYP2C9, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 1.833E-03 | 8.383E-03 | MAPK1, TP53 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 1.895E-03 | 8.383E-03 | MAPK1, TP53 |
09150 Organismal Systems | 09158 Development | hsa04380 | Osteoclast differentiation | 2.287E-03 | 9.740E-03 | MAPK1, PPARG |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 1.895E-03 | 8.383E-03 | MAPK1, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 2.425E-03 | 9.960E-03 | RAB9A, TP53 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | PPARG; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
H00-H59: Diseases of the eye and adnexa | Ocular inflammation | H16.229 | PPARG; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | PPARG; |
K00-K95: Diseases of the digestive system | Non-alcoholic fatty liver disease | K76.0 | PPARG; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Nicotine dependence | F17 | PPARG; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | PPARG; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | PPARG; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | PPARG; |
E00-E89: Endocrine, nutritional and metabolic diseases | Pompe's disease | E74.02 | GAA; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 1 diabetes | E10 | PPARG; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | PPARG; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Drug abuse | F10-F19 | PPARG; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Gout | M10 | PPARG; |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |